Studies have shown that proinflammatory cytokines such as TNF-α, IL-1, IL-6 and IL-17 play important roles in the pathophysiological development of RA and serve as indicators of therapeutic control for RA patients. The gene discussed is TNF; the disease is rheumatoid arthritis.